The Company maintains a stock-based compensation plan, the 2011 Incentive Compensation Plan, as amended (the “2011 Plan”), to attract, motivate, retain and reward employees, directors and consultants by providing its Board or a committee of the Board the discretion to award equity incentives to these persons.

On June 6, 2011, the Company’s stockholders approved the 2011 Plan, which is administered by the Compensation Committee of the Board. The 2011 Plan provides that stock options, stock units, restricted shares, and stock appreciation rights may be granted to executive officers, directors, consultants, and other key employees. In aggregate, as of December 31, 2023, 374,710 shares were available for future grant under the 2011 Plan. At the Company's annual stockholder meeting held on June 28, 2024, the stockholders approved an increase in the number of shares of common stock authorized for issuance under the 2011 Plan by an aggregate of 1,500,000 shares to an aggregate of 6,759,956 shares.

The following is a summary of stock option activity for the year ended December 31, 2024:


	Number Outstanding			Average Exercise Price per Share		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Balance as of January 1, 2024		494,960		$	4.99		2.23	$	1,725,985
Granted		—			—				—
Cancelled or Expired		(50,500	)		10.50				—
Exercised		—			—				—
Balance as of December 31, 2024		444,460		$	4.36		1.43	$	—
Vested or expected to vest as of December 31, 2024		444,460		$	4.36		1.43	$	—
Exercisable as of December 31, 2024		444,460		$	4.36		1.43	$	—

The aggregate intrinsic value in the table above represents the difference between the fair value of the Company’s common stock as of December 31, 2024 and the exercise price of in-the-money stock options multiplied by the number of such stock options.

The following table summarizes information about stock options outstanding as of December 31, 2024:


	Stock Options Outstanding						Stock Options Exercisable
Range of Exercise Prices	Number Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$4.36 - $4.36		444,460		1.43	$	4.36		444,460	$	4.36

On September 6, 2024, in connection with the closing of the Asset Sale and the departure of Steven Humphreys, the Company's former chief executive officer, the Company amended Mr. Humphreys' fully vested stock option award to purchase 444,460 shares of the Company's common stock at an exercise price of $4.36 per share by extending the period of time to exercise the stock option from

three months to twelve months. In the third quarter of 2024, the Company recognized $0.2 million in stock-based compensation related to the modification of the contractual terms of Mr. Humphreys' stock option award. As of December 31, 2024, there was no unrecognized stock-based compensation expense related to stock options.

The following is a summary of RSU activity for the year ended December 31, 2024:


	Number Outstanding			Weighted Average Fair Value
Unvested as of January 1, 2024		730,062		$	11.17
Granted		1,290,040			4.39
Vested		(1,098,132	)		7.19
Forfeited		(114,985	)		7.26
Unvested as of December 31, 2024		806,985		$	6.31
RSUs vested but not released		108,382		$	7.16

The fair value of the Company’s RSUs is calculated based upon the fair market value of the Company’s common stock at the date of grant. As of December 31, 2024, there was $4.0 million of unrecognized compensation cost related to unvested RSUs granted, which is expected to be recognized over a weighted average period of 2.2 years. No tax benefit was realized from RSUs for the year ended December 31, 2024.

At the closing of the Asset Sale, unvested RSUs held by employees who became employed by the Buyer (or an affiliate of Buyer) became fully vested, resulting in the recognition of $3.8 million in stock-based compensation expense in the third quarter of 2024. RSUs held by the Company's remaining employees and its non-employee directors continue to vest according to their original terms.

The Company grants PSUs to certain key employees that are subject to the attainment of performance goals established by the Company’s Compensation Committee, the periods during which performance is to be measured, and other limitations and conditions. Performance goals are based on pre-established objectives that specify the manner of determining the number of PSUs that will vest if performance goals are attained. If an employee terminates employment, the non-vested portion of the PSUs will not vest and all rights to the non-vested portion will terminate.

The following is a summary of PSU activity for the year ended December 31, 2024:


	Number Outstanding			Weighted Average Fair Value
Unvested as of January 1, 2024		—		$	—
Granted		477,500			4.07
Vested		(3,750	)		—
Forfeited		(56,250	)		4.07
Unvested as of December 31, 2024		417,500		$	4.07

As of December 31, 2024, there was $1.3 million of unrecognized compensation expense related to unvested PSUs, which is expected to be recognized over a period of 1.0 years. No tax benefit was realized from PSUs for the year ended December 31, 2024.

The following table summarizes stock-based compensation expense related to stock options, RSUs, and PSUs included in the consolidated statements of comprehensive income (loss) (in thousands):


	Year Ended December 31,
	2024		2023
Cost of revenue	$	22	$	35
Research and development		201		112
Selling and marketing		848		498
General and administrative		2,405		1,424
Stock-based compensation expense - continuing operations		3,476		2,069
Stock-based compensation expense - discontinued operations		5,254		1,902
Total	$	8,730	$	3,971

During the years ended December 31, 2024 and 2023, the Company repurchased 423,679 and 110,753 shares, respectively, of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of RSUs issued to employees.